Skip to main content

Table 2 Cell-loss metric 48 h after the 2nd cycle of therapy

From: Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume

Statistics

Quartile 1

Quartile 2

Quartile 3

Quartile 4

n

26

26

26

26

Mean (Std)*

0.004 (0.002)

0.010 (0.006)

0.029 (0.010)

0.357 (0.469)

Median (min;max)

0.004 (−0.002;0.008)

0.012 (−0.015;0.017)

0.029 (0.010;0.048)

0.203 (0.048;1.881)

Q1, Q3 (IQR)

0.002, 0.005 (0.003)

0.004, 0.013 (0.005)

0.023, 0.038 (0.015)

0.072, 0.432 (0.36)

  1. *Values are units (sTk1, ng x ml−1 / tumor volume, cm3)
  2. Descriptive statistics of the TK1-based cell-loss metric 48 h after the 2nd cycle of chemotherapy among 104 women subdivided into four groups according to quartiles of the TK1 cell-loss metric at baseline
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us